Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1653 participants.

Also called NCT02520180

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,653 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02520180
Other papers using this trial's data
  • 2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent JACC. Cardiovascular interventions, 2019-09-09 DOI, PubMed 31129092
  • Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial Lancet (London, England), 2018-09-29 DOI, PubMed 30190206

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02520180. Randomized; no masking; primary purpose treatment. Start 2015-12 (actual); primary completion 2016-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC)
Intervention (Device)
Firehawk™ stent system
Intervention (Device)
Abbott Xience family Everolimus-Eluting Stent
Lead sponsor
Shanghai MicroPort Medical (Group) Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02520180
Content hash
cf10b65ec525afc6c1489abd373030316b26c143c04b5ee8b00d301734b6dc21